Objectives: To determine the prevalence of generalized and abdominal obesity in urban Asian Indians and compare the association of body mass index (BMI) and waist circumference (WC) with metabolic risk variables. Methods: Subjects were recruited from the Chennai Urban Rural Epidemiology Study (CURES) Conclusions: In Asian Indians, the prevalence of combined obesity is high among both sexes, while isolated generalized obesity is more common in men and isolated abdominal obesity more common in women. However, these prevalence rates vary markedly depending on cut points used. WC is a better marker of obesity-related metabolic risk than BMI in women compared to men in this population.
Introduction
Most available studies on the prevalence of obesity are from developed countries, and there is paucity of data from developing countries. Epidemiological surveys use body mass index (BMI) as an indicator of 'generalized' obesity and waist circumference (WC) or waist-to-hip ratio (WHR) as a measure of 'central' or 'abdominal' obesity. Both generalized and abdominal obesity have been associated with a number of metabolic abnormalities. However, there appear to be ethnic differences in the representative significance (International Diabetes Federation, 2005) . This study reports on the prevalence and significance of generalized and abdominal obesity in urban south Indians.
Study design
Chennai Urban Rural Epidemiology Study (CURES) is a large cross-sectional study done in Chennai in southern India with a population of 5 million people. The study design is described elsewhere (Deepa et al., 2003) , and the sampling frame is available at http://www.drmohansdiabetes.com/ mdrf/CURES.pdf and summarized in Figure 1 .
Phase 1 Phase 1 of CURES was conducted from June 2001 to August 2002, involving a representative sample of 26 001 individuals X20 years of age. Blood pressure and basic anthropometric measures were available in all and fasting capillary blood glucose measurements in 99.3%.
Phase 2
Phase 2 of CURES deals with studies of the prevalence of complications of diabetes.
Phase 3
In Phase 3 of CURES, to maintain the representativeness of the sample as well as considering the logistics involved, every tenth subject recruited in phase 1 (n ¼ 2600) was invited to our center between September 2001 and September 2004 for detailed anthropometric measurements and biochemical tests. Repeated contacts (atleast five) were made by door-to-door visits to ensure better response. Eventually, 2350 participated in the present study (response rate ¼ 90.4%). There were no significant differences in the clinical characteristics of the responders (n ¼ 2,350) and the non-responders (n ¼ 150).
All study subjects underwent an oral glucose tolerance test using 75-gm glucose load, except self-reported diabetic subjects, for whom fasting venous plasma glucose was measured. The fasting sample was taken, after ensuring 8 h of overnight fast, for estimation of plasma glucose and serum lipids using a Hitachi 912 Autoanalyser (Roche Diagnostics GmbH, Mannheim, Germany), utilizing kits supplied by Roche Diagnostics GmbH. Glycated hemoglobin was measured using the Variant machine (Bio-Rad, Hercules, CA, USA). Anthropometric measurements including weight, height, waist and hip measurements were obtained using standardized techniques by two well-trained interviewers (Deepa et al., 2003) . Inter-and intra-observer variability coefficients of variation were o5%.
Height
Height was measured with a tape to the nearest cm. Subjects were requested to stand upright without shoes with their back against the wall, heels together and eyes directed forward.
Weight
Weight was measured with a spring balance that was kept on a firm horizontal surface. Subjects wore light clothing, stood upright without shoes and weight was recorded to the nearest 0.5 kg. The scale was calibrated every day with 'standard' weights. Prevalence and significance of obesity M Deepa et al
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Body mass index
Body mass index was calculated using the formula: weight (kg)/height (m 2 ).
Waist circumference
Waist circumference was measured using a non-stretchable measuring tape. Subjects were asked to stand erect in a relaxed position with both feet together on a flat surface; one layer of clothing was accepted. WC was measured as the smallest horizontal girth between the costal margins and the iliac crests at minimal respiration. Mean of two readings was taken as WC.
Blood pressure
Blood pressure was recorded in the sitting position in the right arm to the nearest 2 mm Hg using mercury sphygmomanometer (Diamond Deluxe, Pune, Maharashtra, India ) (Alberti and Zimmet, 1998) .
Hypertension
Hypertension was diagnosed based on drug treatment for hypertension or BP4130/85 mm Hg (Grundy, 2005) .
Hypercholesterolemia
Hypercholesterolemia was diagnosed if serum cholesterol levels were X200 mg dl À1 (X5.2 mmol l
À1
) or were under drug treatment for hypercholesterolemia (National Cholesterol Education Programme (NCEP), 2001).
Hypertriglyceridemia
Hypertriglyceridemia was diagnosed if serum triglyceride levels were X150 mg dl À1 (X1.7 mmol l À1 ) or were under drug treatment for hypertriglyceridemia (Grundy, 2005) . ) for women (Grundy, 2005) .
Obesity
Generalized obesity was defined using the WHO Expert Consultation guidelines (WHO Expert Consultation, 2004) as BMIX23 kg m À2 and abdominal obesity as WCX90 cm for men and X80 cm for women (WHO, 2000) .
Metabolic risk factors
Metabolic risk factors were defined based on revised ATP III definition for Asian Indians (Grundy, 2005) as shown in Table 5 .
Statistics
Statistical analyses were performed using SPSS for windows version 10.0 software (SPSS Inc., Chicago, IL, USA). Student's t-tests were used for continuous variable and w 2 test for proportions, and all comparisons were only between two groups. The prevalence rate obtained in the present study was age-standardized to the 2001 Census of India. Correlation between the obesity indices and the metabolic risk variables was done using bivariate correlation analysis. Sensitivity and specificity of BMI and WC cut points were estimated for determining the presence or absence of various metabolic risk factors. The area under the receiver operating characteristic curves and the 95% confidence intervals (CIs) were computed. Association of obesity indices with metabolic risk factors were computed using multiple logistic regression analysis after adjusting for age. P-value o0.05 was considered significant.
Results
Characteristics of the study subjects are shown in Table 1 . The mean age of the study population was 40713 years, and 47% of subjects were men. Men were older, had higher WC, WHR, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, serum triglycerides and glycated hemoglobin (Po0.001 for all except fasting plasma glucose Po0.05) compared to women. Women had a higher BMI (Po0.05), hip circumference (Po0.001) and high-density lipoprotein cholesterol compared to men. Men had higher prevalence of diabetes compared to women; however, there is no significant difference in the prevalence of IGT between men and women. The socioeconomic status of the population was categorized as monthly income level less than Rs. 5000 (72.6%), Rs. 5000-10 000 (22.3%) and above Rs. 10 000 (5.1%) (1 US$ ¼ Rs. 43 approximately).
Prevalence of obesity (generalized and abdominal) Table 2 shows the crude-and age-standardized prevalence of generalized obesity based on different BMI cut points. The overall age-standardized prevalence of obesity using the international (western) definition of BMIX30 was 4.0%, CI: 3.2-4.8%, (women: 4.6%4 men: 3.3%, P ¼ 0.135). However, using the BMIX27.5, it was 9.9%, CI: 8.7-11.1%, (women: 10.7%4 men: 8.6%, P ¼ 0.085), while using the Asia Pacific definition of obesity BMIX25, it was 26.5%, CI: 24.7-28.3%, (women: 29.4%4 men: 22.8%, P ¼ 0.004), and finally, using the new definition of BMIX23, it was 45.9% CI: 43.9-47.9% (women: 47.4%4 men: 43.2%, P ¼ 0.210). The age-standardized prevalence of abdominal obesity using Asia Pacific definition (WC: men X90 cm and women X80 cm) was 46.6%, CI: 44.6-48.6% (women: 56.2%4 men: 35.1%, Po0.001).
The prevalence of generalized obesity ( Figure 2a ) and abdominal obesity (Figure 2b ) increased until the age of 50 years in both men and women and decreased thereafter. The prevalence of generalized obesity (BMIX23) did not vary significantly between the sexes, except for the age group of 20-29 years, where women had significantly higher prevalence compared to men (Po0.05). The prevalence of abdominal obesity was significantly higher in women till the age of 60 years (Po0.05) after which the significance disappeared.
Prevalence of isolated abdominal and isolated generalized obesity Isolated abdominal obesity (increased WC, BMIo23) was present in 4.7% of men and 14% of women (Table 3 ). The prevalence of isolated generalized obesity (normal WC, BMIX23) was 12.7% in men and 6.1% in women. Combined obesity (that is generalized plus abdominal) was seen in 32.6% of men and 43.3% of women. Men with isolated abdominal obesity had higher prevalence of all cardiovascular risk factors (diabetes, hypertriglyceridemia, hypercholesterolemia and low high-density lipoprotein cholesterol) except hypertension, compared with those with combined obesity. Women with combined obesity had higher prevalence of all cardiovascular risk factors (except hypercholesterolemia) compared with those with isolated abdominal and generalized obesity.
Prevalence of obesity among subjects with different degrees of glucose intolerance In women, the prevalence of generalized obesity was highest in subjects with diabetes (72.6%) compared to those with IGT (66.2%) and normal glucose tolerance (43.9%) (trend w 2 : 62.8, Po0.001). In men, the prevalence was highest in subjects with IGT (normal glucose tolerance: 39.8%, ) for women or on drug treatment. *Po0.001 and # Po0.05 compared to subjects with normal waist and normal BMI.
The age-adjusted odds ratios for predicting metabolic risk factors using BMIX23 ranged from 0.74 for any one risk factor to 3.23 for identifying any three risk factors (Table 5) . Using the WC cut point, in men it ranged from 0.69 for any one risk factor to 2.81 for any three risk factors. In women, it ranged from 0.72 for any one risk factor to 4.09 for any three risk factors.
Discussion
This study shows the following results in urban Asian Indians studied at Chennai in southern India, using WHO Asia Pacific guidelines to define generalized and abdominal obesity: (i) the age-standardized prevalence of generalized obesity (BMIX23 kg m À2 ) was 45.9%, while that of abdominal obesity was 46.6%; (ii) isolated generalized obesity was more common in men and isolated abdominal obesity more common in women; and (iii) abdominal obesity showed greater correlation with cardiometabolic abnormalities than generalized obesity.
The age-standardized prevalence rate of generalized obesity in urban South Indians in this study was 4% using BMIX30; 9.9% using BMIX27.5; 26.5% using BMIX25; and 45.9% using BMIX23 kg m
À2
. This is quite similar to figures reported from other Asian countries. The Chinese National Nutrition Survey showed that the prevalence of obesity (BMIX25) was 17.2% in Shanghai, 26.5% in Tianjin and 32.8% in Beijing (Ge, 1997) . Using (BMIX30), the prevalence of obesity (BMIX30) among Hong Kong Chinese population was 2.2% in men and 4.8% in women, while using a cut point of BMIX27 in men and X25 in women, the prevalence was 10% in men and 27.9% in women (Ko et al., 1997) . In Malaysia, the prevalence of obesity using BMI (25-30) was 24% in men and 18.1% in women, while using BMI430, it was 4.7% in men and 7.7% in women (Ismail et al., 1995) . In Thailand, the prevalence of obesity was 16.7% using the cut point of BMI 25-30 and 4% using BMI430 (Chuprapavarn, 1996) .
The age-standardized prevalence of abdominal obesity in the present study was 46.6% (men: 35.1%, women: 56.2%, Po0.001). Prevalence rates of abdominal obesity (WC: men X102 cm and women X88 cm) were reported to be 27.1, 20.2 and 21.4% for white, black and hispanic men, and corresponding figures were 43.2, 56 and 55.4% for white, black and hispanic women, respectively, in the United States (Okosun et al., 1999) . Hong Kong Chinese women had much Abbreviation: HDL, high-density lipoprotein. All variables are adjusted for age and gender. 'r' is correlation coefficient higher prevalence of abdominal obesity (22.5%) (WC: men X94 cm and women X80 cm) compared to men (4.5%). A case-control study in Nagpur, Maharashtra, India showed that abdominal obesity using WC is a better predictor of the risk of diabetes compared to WHR, abdominal volume index and conicity index (Mamtani and Kulkarni, 2005) . The Heart Outcomes Prevention Evaluation (HOPE) study reported that abdominal adiposity worsens the prognosis of patients with cardiovascular disease (CVD) (Dagenais et al., 2005) . Our study shows that in men, at all age groups, generalized obesity is higher compared to abdominal obesity (except at 60-69 years). Among women, abdominal obesity is higher than generalized obesity. However, when we raised the cut point to BMIX25 kg m À2 , isolated generalized obesity was found in only 2.9% of men and 1.6% of women; whereas, isolated abdominal obesity was found in 16.6% of men and 28.7% of women (data not shown). It is worth emphasizing that the prevalence of generalized obesity ranged from 4.3 to 48.3% in the same population studied depending on the cut points used. It is therefore clear that defining obesity either by BMI or WC is purely arbitrary, and the figures can vary widely based on the cut points used. Thus, data from different ethnic groups using different obesity index cut points should be interpreted with caution. Studies by Kumar et al. (2006) reported that there is a large difference in generalized and central obesity between immigrant groups from developing countries, especially in south Asians. In this study also, we find that WC yields higher correlation coefficients for metabolic risk factors compared to BMI, suggesting that WC may be a better index than BMI to identify metabolic risk factors in Asian Indians. However, there is need for prospective studies to confirm these findings.
It is of interest that 10% of subjects without generalized obesity and 10.4% of subjects without abdominal obesity had diabetes in this study. This shows that the risk of developing diabetes starts even at 'normal' BMI and WC in our population. Indeed, four of the five countries with the most cases of diabetes are in Asia, and the risk of diabetes has been shown to start at a much lower BMI (Nakagami et al., 2003; Yajnik, 2006) and WC (Vikram et al., 2003) in Asians compared to Europeans. High cardiovascular-related morbidities at upper 'normal' BMI range have been reported in several Asian countries including Korea (Moon et al., 2002) , Singapore (Deurenberg-Yap et al., 2001) , Japan (Ito et al., 2003) and Taiwan (Lin et al., 2002) .
Waist-to-hip ratio, which is another useful measure of abdominal obesity, was not included in this analysis, because this article aims to study the impact of generalized obesity (measured by BMI) and abdominal obesity (measured by WC) in predicting metabolic risk factors. However, it would be of interest to study the association of WHR with metabolic risk factors in future studies, as the INTERHEART study based on data from 52 countries has shown the importance of WHR, and indeed, the 'protective' effect of hip circumference .
Studies by Yajnik (2004 Yajnik ( , 2006 have reported the association between WHR and hyperglycemia and have demonstrated that the higher WHR represents an exaggerated thrifty phenotype due to nutritional transition: small hips represent fetal deprivation and a large waist the subsequent abundance. Pua and Ong (2005) showed that obesity indices like BMI, WC, WHR and waist-to-stature ratio complemented one another, and the latter proved to be the best anthropometric index for screening cardiovascular disease risk factors among Singaporean women. A meta-analysis of prospective studies emphasized the importance of incorporating WHR or WC into cardiovascular disease risk assessment (de Koning et al., 2007) . Metabolic and vascular risks for obesity are manifested at a lower BMI in developing countries compared with those in developed countries (Deurenberg-Yap et al., 2002) . The strengths of the present study are that the subjects studied are representative of the urban population of Chennai, the sample size is large (n ¼ 2350) and the response rate is good (90.4%). However, there are several limitations. First, while representative of urban India, this data cannot be applied to rural India where 70% of India's population lives. Second, the cross-sectional nature of the design does not allow for cause-effect relationships to be made. Finally, the conclusions were based on metabolic risk factors rather than clinical end points or mortality data. Prospective studies are needed to address these issues and to determine the relationship of obesity-to disease-related end points in South Asians.
The following three important findings from the public health perspective emerge from the present study: (a) the prevalence of obesity, both generalized and abdominal is alarmingly high in this population; (b) isolated generalized obesity is more common in men, whereas isolated abdominal obesity is more common in women in this population; (c) abdominal obesity shows a greater correlation with cardiometabolic abnormalities. These findings suggest that in Asian Indians, measuring WC is a better method of estimating obesity-related cardiovascular disease risk than BMI. These findings lend further support for the inclusion of WC as a component of Indian Diabetes Risk Score (IDRS), which has been shown to be a very effective tool for predicting undiagnosed diabetes (Mohan et al., 2005) and also for identifying the metabolic syndrome (Mohan et al., 2006) in this population. We intend to follow up this cohort prospectively for outcome events, which could provide more definite information regarding the relationship of obesity indices with cardiovascular mortality and/or morbidity.
